450
Views
33
CrossRef citations to date
0
Altmetric
Review

PCR methodology and applications for the detection of human fungal pathogens

&
Pages 1025-1036 | Received 14 Jun 2016, Accepted 28 Jul 2016, Published online: 08 Aug 2016

References

  • Khot PD, Fredricks DN. PCR-based diagnosis of human fungal infections. Expert Rev Anti Infect Ther. 2009;7(10):1201–1221.
  • Walsh TJ, Gamaletsou MN, McGinnis MR, et al. Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis). Clin Infect Dis. 2012;54(Suppl 1):S55–S60.
  • Odabasi Z, Mattiuzzi G, Estey E, et al. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis. 2004;39(2):199–205.
  • Bastien P, Procop GW, Reischl U. Quantitative real-time PCR is not more sensitive than “conventional” PCR. J Clin Microbiol. 2008;46(6):1897–1900.
  • Francesconi A, Kasai M, Harrington SM, et al. Automated and manual methods of DNA extraction for Aspergillus fumigatus and Rhizopus oryzae analyzed by quantitative real-time PCR. J Clin Microbiol. 2008;46(6):1978–1984.
  • Lõoke M, Kristjuhan K, Kristjuhan A. Extraction of genomic DNA from yeasts for PCR-based applications. Biotechniques. 2011;50(5):325–328.
  • Mai M, Müller I, Maneg D, et al. Real-time PCR-based identification of bacterial and fungal pathogens from blood samples. Methods Mol Biol. 2015;1237:139–147.
  • Watzinger F, Suda M, Preuner S, et al. Real-time quantitative PCR assays for detection and monitoring of pathogenic human viruses in immunosuppressed pediatric patients. J Clin Microbiol. 2004;42(11):5189–5198.
  • Järvinen A-K, Laakso S, Piiparinen P, et al. Rapid identification of bacterial pathogens using a PCR- and microarray-based assay. BMC Microbiol. 2009;9:161.
  • Weiss JB. DNA probes and PCR for diagnosis of parasitic infections. Clin Microbiol Rev. 1995;8(1):113–130.
  • Boch T, Reinwald M, Postina P, et al. Identification of invasive fungal diseases in immunocompromised patients by combining an Aspergillus specific PCR with a multifungal DNA-microarray from primary clinical samples. Mycoses. 2015;58(12):735–745.
  • Mylonakis E, Clancy CJ, Ostrosky-Zeichner L, et al. T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial. Clin Infect Dis. 2015;60(6):892–899.
  • Shepard JR, Addison RM, Alexander BD, et al. Multicenter evaluation of the Candida albicans/Candida glabrata peptide nucleic acid fluorescent in situ hybridization method for simultaneous dual-color identification of C. albicans and C. glabrata directly from blood culture bottles. J Clin Microbiol. 2008;46(1):50–55.
  • Muñoz P, Burillo A, Bouza E. Environmental surveillance and other control measures in the prevention of nosocomial fungal infections. Clin Microbiol Infect. 2001;7(Suppl 2):38–45.
  • Sobel JD, Akins RA. The role of PCR in the diagnosis of Candida vulvovaginitis – a new gold standard? Curr Infect Dis Rep. 2015;17(6):488.
  • McMullan R, Metwally L, Coyle PV, et al. A prospective clinical trial of a real-time polymerase chain reaction assay for the diagnosis of candidemia in nonneutropenic, critically ill adults. Clin Infect Dis. 2008;46(6):890–896.
  • Enache-Angoulvant A, Guitard J, Grenouillet F, et al. Rapid discrimination between Candida glabrata, Candida nivariensis, and Candida bracarensis by use of a singleplex PCR. J Clin Microbiol. 2011;49(9):3375–3379.
  • Fricke S, Fricke C, Schimmelpfennig C, et al. A real-time PCR assay for the differentiation of Candida species. J Appl Microbiol. 2010;109(4):1150–1158.
  • McMullan R, Metwally L, Troughton JA, et al. The impact of a PCR assay for candidemia on antifungal drug prescribing in critical care: an interrupted time series pilot study. J Infect. 2010;61(1):81–85.
  • Neely LA, Audeh M, Phung NA, et al. T2 magnetic resonance enables nanoparticle-mediated rapid detection of candidemia in whole blood. Sci Transl Med. 2013;5(182):182ra54.
  • Walker B, Powers-Fletcher MV, Schmidt RL, et al. Cost-effectiveness analysis of multiplex PCR with magnetic resonance detection versus empiric or blood culture-directed therapy for management of suspected candidemia. J Clin Microbiol. 2016;54(3):718–726.
  • Ogundeji AO, Albertyn J, Pohl CH, et al. Method for identification of Cryptococcus neoformans and Cryptococcus gattii useful in resource-limited settings. J Clin Pathol. 2016;69(4):352–357.
  • Chakrabarti A. Epidemiology of central nervous system mycoses. Neurol India. 2007;55(3):191–197.
  • Klein KR, Hall L, Deml SM, et al. Identification of Cryptococcus gattii by use of L-canavanine glycine bromothymol blue medium and DNA sequencing. J Clin Microbiol. 2009;47(11):3669–3672.
  • Chae HS, Park GN, Kim SH, et al. Rapid direct identification of Cryptococcus neoformans from pigeon droppings by nested PCR using CNLAC1 gene. Poult Sci. 2012;91(8):1983–1989.
  • Leal AL, Faganello J, Bassanesi MC, et al. Cryptococcus species identification by multiplex PCR. Med Mycol. 2008;46(4):377–383.
  • Chapin-Robertson K, Bechtel C, Waycott S, et al. Cryptococcal antigen detection from the urine of AIDS patients. Diagn Microbiol Infect Dis. 1993;17(3):197–201.
  • Tanner DC, Weinstein MP, Fedorciw B, et al. Comparison of commercial kits for detection of cryptococcal antigen. J Clin Microbiol. 1994;32(7):1680–1684.
  • Hansen J, Slechta ES, Gates-Hollingsworth MA, et al. Large-scale evaluation of the immuno-mycologics lateral flow and enzyme-linked immunoassays for detection of cryptococcal antigen in serum and cerebrospinal fluid. Clin Vaccine Immunol. 2013;20(1):52–55.
  • Rappelli P, Are R, Casu G, et al. Development of a nested PCR for detection of Cryptococcus neoformans in cerebrospinal fluid. J Clin Microbiol. 1998;36(11):3438–3440.
  • Rhein J, Bahr NC, Hemmert AC, et al. Diagnostic performance of a multiplex PCR assay for meningitis in an HIV-infected population in Uganda. Diagn Microbiol Infect Dis. 2016;84(3):268–273.
  • Walsh TJ, Hier DB, Caplan LR. Fungal infections of the central nervous system: comparative analysis of risk factors and clinical signs in 57 patients. Neurology. 1985;35(11):1654–1657.
  • McCarthy M, Rosengart A, Schuetz AN, et al. Mold infections of the central nervous system. N Engl J Med. 2014;371(2):150–160.
  • Ben-Ami R, Lewis RE, Raad II, et al. Phaeohyphomycosis in a tertiary care cancer center. Clin Infect Dis. 2009;48(8):1033–1041.
  • Katragkou A, Pana Z-D, Perlin DS, et al. Exserohilum infections: review of 48 cases before the 2012 United States outbreak. Med Mycol. 2014;52(4):376–386.
  • Bennett JW. Aspergillus: a primer for the novice. Med Mycol. 2009;47(Suppl 1):S5–12.
  • Iihara K, Makita Y, Nabeshima S, et al. Aspergillosis of the central nervous system causing subarachnoid hemorrhage from mycotic aneurysm of the basilar artery – case report. Neurol Med Chir (Tokyo). 1990;30(8):618–623.
  • Al-Shair K, Muldoon EG, Morris J, et al. Characterisation of fatigue and its substantial impact on health status in a large cohort of patients with chronic pulmonary aspergillosis (CPA). Respir Med. 2016;114:117–122.
  • Kadota J. Update and recent advances on the management of invasive and chronic pulmonary aspergillosis. Respir Investig. 2016;54(2):75.
  • Rhine WD, Arvin AM, Stevenson DK. Neonatal aspergillosis. A case report and review of the literature. Clin Pediatr (Phila). 1986;25(8):400–403.
  • Buchheidt D, Reinwald M, Spiess B, et al. Biomarker-based diagnostic work-up of invasive pulmonary aspergillosis in immunocompromised paediatric patients – is Aspergillus PCR appropriate? Mycoses. 2016;59(2):67–74.
  • Kawazu M, Kanda Y, Nannya Y, et al. Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1–>3)-beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders. J Clin Microbiol. 2004;42(6):2733–2741.
  • Arvanitis M, Ziakas PD, Zacharioudakis IM, et al. PCR in diagnosis of invasive aspergillosis: a meta-analysis of diagnostic performance. J Clin Microbiol. 2014;52(10):3731–3742.
  • Springer J, Lackner M, Nachbaur D, et al. Prospective multicentre PCR-based Aspergillus DNA screening in high-risk patients with and without primary antifungal mould prophylaxis. Clin Microbiol Infect. 2016;22(1):80–86.
  • Hoenigl M, Prattes J, Spiess B, et al. Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol. 2014;52(6):2039–2045.
  • Paholcsek M, Fidler G, Konya J, et al. Combining standard clinical methods with PCR showed improved diagnosis of invasive pulmonary aspergillosis in patients with hematological malignancies and prolonged neutropenia. BMC Infect Dis. 2015;15:251.
  • Camuset J, Nunes H, Dombret M-C, et al. Treatment of chronic pulmonary aspergillosis by voriconazole in nonimmunocompromised patients. Chest. 2007;131(5):1435–1441.
  • Denning DW, Park S, Lass-Florl C, et al. High-frequency triazole resistance found In nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease. Clin Infect Dis. 2011;52(9):1123–1129.
  • White PL, Barnes RA, Springer J, et al. Clinical performance of Aspergillus PCR for testing serum and plasma: a study by the European Aspergillus PCR Initiative. J Clin Microbiol. 2015;53(9):2832–2837.
  • Tirodker UH, Nataro JP, Smith S, et al. Detection of fungemia by polymerase chain reaction in critically ill neonates and children. J Perinatol. 2003;23(2):117–122.
  • Reinwald M, Konietzka CAM, Kolve H, et al. Assessment of Aspergillus-specific PCR as a screening method for invasive aspergillosis in paediatric cancer patients and allogeneic haematopoietic stem cell recipients with suspected infections. Mycoses. 2014;57(9):537–543.
  • Reinwald M, Buchheidt D, Hummel M, et al. Diagnostic performance of an Aspergillus-specific nested PCR assay in cerebrospinal fluid samples of immunocompromised patients for detection of central nervous system aspergillosis. PLoS One. 2013;8(2):e56706.
  • Imbert S, Gauthier L, Joly I, et al. Aspergillus PCR in serum for the diagnosis, follow-up and prognosis of invasive aspergillosis in neutropenic and nonneutropenic patients. Clin Microbiol Infect. 2016;22:562.e1-562.e8.
  • Spellberg B, Ibrahim AS, Chin-Hong PV, et al. The deferasirox-ambisome therapy for mucormycosis (DEFEAT mucor) study: a randomized, double-blinded, placebo-controlled trial. J Antimicrob Chemother. 2012;67(3):715–722.
  • Yu J, Walther G, Van Diepeningen AD, et al. DNA barcoding of clinically relevant Cunninghamella species. Med Mycol. 2015;53(2):99–106.
  • Kauffman CA, Malani AN. Zygomycosis: an emerging fungal infection with new options for management. Curr Infect Dis Rep. 2007;9(6):435–440.
  • Reed C, Bryant R, Ibrahim AS, et al. Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis. Clin Infect Dis. 2008;47(3):364–371.
  • Alanio A, Garcia-Hermoso D, Mercier-Delarue S, et al. Molecular identification of Mucorales in human tissues: contribution of PCR electrospray-ionization mass spectrometry. Clin Microbiol Infect. 2015;21(6):594.e1-594.e5.
  • Hammond SP, Bialek R, Milner DA, et al. Molecular methods to improve diagnosis and identification of mucormycosis. J Clin Microbiol. 2011;49(6):2151–2153.
  • Kasai M, Harrington SM, Francesconi A, et al. Detection of a molecular biomarker for zygomycetes by quantitative PCR assays of plasma, bronchoalveolar lavage, and lung tissue in a rabbit model of experimental pulmonary zygomycosis. J Clin Microbiol. 2008;46(11):3690–3702.
  • Kaleta EJ, Clark AE, Johnson DR, et al. Use of PCR coupled with electrospray ionization mass spectrometry for rapid identification of bacterial and yeast bloodstream pathogens from blood culture bottles. J Clin Microbiol. 2011;49(1):345–353.
  • Massire C, Buelow DR, Zhang SX, et al. PCR followed by electrospray ionization mass spectrometry for broad-range identification of fungal pathogens. J Clin Microbiol. 2013;51(3):959–966.
  • Dignani MC, Anaissie E. Human fusariosis. Clin Microbiol Infect. 2004;10(Suppl 1):67–75.
  • Demeke T, Clear RM, Patrick SK, et al. Species-specific PCR-based assays for the detection of Fusarium species and a comparison with the whole seed agar plate method and trichothecene analysis. Int J Food Microbiol. 2005;103(3):271–284.
  • Ikeda I, Ohno T, Ohno H, et al. Case of Fusarium paronychia successfully treated with occlusive dressing of antifungal cream. J Dermatol. 2014;41(4):340–342.
  • Nucci M, Anaissie E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev. 2007;20(4):695–704.
  • Hayden RT, Isotalo PA, Parrett T, et al. In situ hybridization for the differentiation of Aspergillus, Fusarium, and Pseudallescheria species in tissue section. Diagn Mol Pathol. 2003;12(1):21–26.
  • Beck-Sagué C, Jarvis WR. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. J Infect Dis. 1993;167(5):1247–1251.
  • Anaissie EJ, Kuchar RT, Rex JH, et al. Fusariosis associated with pathogenic Fusarium species colonization of a hospital water system: a new paradigm for the epidemiology of opportunistic mold infections. Clin Infect Dis. 2001;33(11):1871–1878.
  • Perlroth J, Choi B, Spellberg B. Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Med Mycol. 2007;45(4):321–346.
  • Graça MG, Van Der Heijden IM, Perdigão L, et al. Evaluation of two methods for direct detection of Fusarium spp. in water. J Microbiol Methods. 2016;123:39–43.
  • Salaki JS, Louria DB, Chmel H. Fungal and yeast infections of the central nervous system. A clinical review. Medicine(Baltimore). 1984;63(2):108–132.
  • Qureshi ZA, Kwak EJ, Nguyen MH, et al. Ochroconis gallopava: a dematiaceous mold causing infections in transplant recipients. Clin Transplant. 2012;26(1):E17–E23.
  • Kordalewska M, Brillowska-Dąbrowska A, Jagielski T, et al. PCR and real-time PCR assays to detect fungi of Alternaria alternata species. Acta Biochim Pol. 2015;62(4):707–712.
  • Develoux M, Dieng M-T, Ndiaye B, et al. [Chromomycosis caused by Exophilia spinifera in Sahelian Africa]. Ann Dermatol Venereol. 2006;133(1):68–69.
  • Wang L, Al-Hatmi AMS, Lai X, et al. Bipolaris oryzae, a novel fungal opportunist causing keratitis. Diagn Microbiol Infect Dis. 2016;85(1):61–65.
  • Alex D, Li D, Calderone R, et al. Identification of Curvularia lunata by polymerase chain reaction in a case of fungal endophthalmitis. Med Mycol Case Rep. 2013;2:137–140.
  • Zhao Y, Petraitiene R, Walsh TJ, et al. A real-time PCR assay for rapid detection and quantification of Exserohilum rostratum, a causative pathogen of fungal meningitis associated with injection of contaminated methylprednisolone. J Clin Microbiol. 2013;51(3):1034–1036.
  • Mariné M, Pastor FJ, Guarro J. Combined antifungal therapy in a murine model of disseminated infection by Cladophialophora bantiana. Med Mycol. 2009;47(1):45–49.
  • Li DM, De Hoog GS. Cerebral phaeohyphomycosis – a cure at what lengths? Lancet Infect Dis. 2009;9(6):376–383.
  • Abliz P, Fukushima K, Takizawa K, et al. Specific oligonucleotide primers for identification of Cladophialophora carrionii, a causative agent of chromoblastomycosis. J Clin Microbiol. 2004;42(1):404–407.
  • Arvanitis M, Anagnostou T, Fuchs BB, et al. Molecular and nonmolecular diagnostic methods for invasive fungal infections. Clin Microbiol Rev. 2014;27(3):490–526.
  • Babady NE, Buckwalter SP, Hall L, et al. Detection of Blastomyces dermatitidis and Histoplasma capsulatum from culture isolates and clinical specimens by use of real-time PCR. J Clin Microbiol. 2011;49(9):3204–3208.
  • Chu JH, Feudtner C, Heydon K, et al. Hospitalizations for endemic mycoses: a population-based national study. Clin Infect Dis. 2006;42(6):822–825.
  • Tang Y-W, Li H, Durkin MM, et al. Urine polymerase chain reaction is not as sensitive as urine antigen for the diagnosis of disseminated histoplasmosis. Diagn Microbiol Infect Dis. 2006;54(4):283–287.
  • Hage CA, Ribes JA, Wengenack NL, et al. A multicenter evaluation of tests for diagnosis of histoplasmosis. Clin Infect Dis. 2011;53(5):448–454.
  • Binnicker MJ, Buckwalter SP, Eisberner JJ, et al. Detection of Coccidioides species in clinical specimens by real-time PCR. J Clin Microbiol. 2007;45(1):173–178.
  • Wieden MA, Lundergan LL, Blum J, et al. Detection of coccidioidal antibodies by 33-kDa spherule antigen, Coccidioides EIA, and standard serologic tests in sera from patients evaluated for coccidioidomycosis. J Infect Dis. 1996;173(5):1273–1277.
  • Buitrago MJ, Merino P, Puente S, et al. Utility of real-time PCR for the detection of Paracoccidioides brasiliensis DNA in the diagnosis of imported paracoccidioidomycosis. Med Mycol. 2009;47(8):879–882.
  • Mirhendi H, Motamedi M, Makimura K, et al. Development a diagnostic pan-dermatophyte TaqMan probe real-time PCR assay based on beta tubulin gene. Mycoses. 2016;59:520–527.
  • Liu Z, Liu Y, Feng X, et al. Innate immune molecule surfactant protein d attenuates sepsis-induced acute pancreatic injury through modulating apoptosis and NF-κB-mediated inflammation. Sci Rep. 2015;5:17798.
  • Trikudanathan G, Navaneethan U, Vege SS. Intra-abdominal fungal infections complicating acute pancreatitis: a review. Am J Gastroenterol. 2011;106(7):1188–1192.
  • Zhang W-Z, Han T-Q, Tang Y-Q, et al. Rapid diagnosis of fungal infection in patients with acute necrotizing pancreatitis by polymerase chain reaction. Asian J Surg. 2002;25(3):209–213.
  • Badiee P, Jafarpour Z, Alborzi A, et al. Orbital mucormycosis in an immunocompetent individual. Iran J Microbiol. 2012;4(4):210–214.
  • Schwiertz A, Taras D, Rusch K, et al. Throwing the dice for the diagnosis of vaginal complaints? Ann Clin Microbiol Antimicrob. 2006;5:4.
  • Mahmoudi Rad M, Zafarghandi AS, Amel Zabihi M, et al. Identification of Candida species associated with vulvovaginal candidiasis by multiplex PCR. Infect Dis Obstet Gynecol. 2012;2012:872169.
  • Kaur R, Wadhwa A, Bhalla P, et al. Pneumocystis pneumonia in HIV patients: a diagnostic challenge till date. Med Mycol. 2015;53(6):587–592.
  • Matsumura Y, Ito Y, Yamamoto M, et al. Pneumocystis polymerase chain reaction and blood (1→3)-β-D-glucan assays to predict survival with suspected Pneumocystis jirovecii pneumonia. J Infect Chemother. 2014;20(2):109–114.
  • Church DL, Ambasta A, Wilmer A, et al. Development and validation of a Pneumocystis jirovecii real-time polymerase chain reaction assay for diagnosis of Pneumocystis pneumonia. Can J Infect Dis Med Microbiol. 2015;26(5):263–267.
  • Fujisawa T, Suda T, Matsuda H, et al. Real-time PCR is more specific than conventional PCR for induced sputum diagnosis of Pneumocystis pneumonia in immunocompromised patients without HIV infection. Respirology. 2009;14(2):203–209.
  • To KKW, Wong SCY, Xu T, et al. Use of nasopharyngeal aspirate for diagnosis of pneumocystis pneumonia. J Clin Microbiol. 2013;51(5):1570–1574.
  • Nevez G, Totet A, Pautard J-C, et al. Pneumocystis carinii detection using nested-PCR in nasopharyngeal aspirates of immunocompetent infants with bronchiolitis. J Eukaryot Microbiol. 2001;48(Suppl):122S–123S.
  • Azoulay E, Bergeron A, Chevret S, et al. Polymerase chain reaction for diagnosing pneumocystis pneumonia in non-HIV immunocompromised patients with pulmonary infiltrates. Chest. 2009;135(3):655–661.
  • Mühlethaler K, Bögli-Stuber K, Wasmer S, et al. Quantitative PCR to diagnose Pneumocystis pneumonia in immunocompromised non-HIV patients. Eur Respir J. 2012;39(4):971–978.
  • Alanio A, Bretagne S. Difficulties with molecular diagnostic tests for mould and yeast infections: where do we stand? Clin Microbiol Infect. 2014;20(Suppl 6):36–41.
  • Chandler JA, Liu RM, Bennett SN. RNA shotgun metagenomic sequencing of Northern California (USA) mosquitoes uncovers viruses, bacteria, and fungi. Front Microbiol. 2015;6:185.
  • Huffnagle GB, Noverr MC. The emerging world of the fungal microbiome. Trends Microbiol. 2013;21(7):334–341.
  • Shelburne SA, Ajami NJ, Chibucos MC, et al. Implementation of a pan-genomic approach to investigate holobiont-infecting microbe interaction: a case report of a leukemic patient with invasive mucormycosis. PLoS One. 2015;10(11):e0139851.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.